Companies / Biohaven Pharmaceuticals
Biohaven Pharmaceuticals
United States
Biohaven is a biopharmaceutical company focused on the discovery, development and commercialization of life-changing treatments in key therapeutic areas including immunology, obesity, neuroscience and oncology.
Biohaven Pharmaceuticals, based in United States, has 3 investors on file, among them Aisling Capital, Aperture Venture Partners and Connecticut Innovations.
Investors
3 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital |
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Biohaven Pharmaceuticals and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Aisling Capital adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/biohavenpharma.com/investors
# also
GET /v1/companies/biohavenpharma.com
GET /v1/companies/biohavenpharma.com/news